Dihydrorotenone

CAS No. 6659-45-6

Dihydrorotenone( —— )

Catalog No. M24675 CAS No. 6659-45-6

Dihydrorotenone is a potent mitochondrial inhibitor and probably induces Parkinsonian syndrome.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 271 In Stock
5MG 263 In Stock
10MG 421 In Stock
25MG 696 In Stock
50MG 918 In Stock
100MG 1237 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydrorotenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrorotenone is a potent mitochondrial inhibitor and probably induces Parkinsonian syndrome.
  • Description
    Dihydrorotenone is a potent mitochondrial inhibitor and probably induces Parkinsonian syndrome.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis|Mitochondrial Metabolism
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6659-45-6
  • Formula Weight
    396.43
  • Molecular Formula
    C23H24O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC(C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Natural pesticide dihydrorotenone arrests human plasma cancer cells at the G0/G1 phase of the cell cycle.J Biochem Mol Toxicol. 2014 May;28(5):232-8.
molnova catalog
related products
  • EC359

    EC359 is a potent and selective inhibitor of leukemia inhibitory factor receptor (LIFR), a potent inhibitor with anticancer activity, blocks LIF/LIFR interaction, and can be used in the study of leukemia and endometrial cancer.

  • Sophoraflavanone G

    Sophoraflavanone G (Kushenol F) isolated from Sophora flavescens induces MDA-MB-231 and HL-60 cells apoptosis through suppression of MAPK-related pathways.

  • Mardepodect hydrochl...

    Mardepodect hydrochloride (Mardepodect HCl) is an orally active, selective and potent inhibitor of PDE10A that crosses the blood-brain barrier (IC50: 0.37 nM).